Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 1;24(2):143-168.
doi: 10.1097/PCC.0000000000003147. Epub 2023 Jan 20.

Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2)

Guillaume Emeriaud  1 Yolanda M López-Fernández  2 Narayan Prabhu Iyer  3 Melania M Bembea  4 Asya Agulnik  5 Ryan P Barbaro  6 Florent Baudin  7 Anoopindar Bhalla  8 Werther Brunow de Carvalho  9 Christopher L Carroll  10 Ira M Cheifetz  11 Mohammod J Chisti  12 Pablo Cruces  13   14 Martha A Q Curley  15   16 Mary K Dahmer  6 Heidi J Dalton  17 Simon J Erickson  18 Sandrine Essouri  1 Analía Fernández  19 Heidi R Flori  6 Jocelyn R Grunwell  20 Philippe Jouvet  1 Elizabeth Y Killien  21 Martin C J Kneyber  22 Sapna R Kudchadkar  4   23 Steven Kwasi Korang  8   24 Jan Hau Lee  25 Duncan J Macrae  26 Aline Maddux  27 Vicent Modesto I Alapont  28 Brenda M Morrow  29 Vinay M Nadkarni  30 Natalie Napolitano  31 Christopher J L Newth  8 Martí Pons-Odena  32 Michael W Quasney  6 Prakadeshwari Rajapreyar  33 Jerome Rambaud  34 Adrienne G Randolph  35 Peter Rimensberger  36 Courtney M Rowan  37 L Nelson Sanchez-Pinto  38 Anil Sapru  39 Michael Sauthier  1 Steve L Shein  11 Lincoln S Smith  40 Katerine Steffen  41 Muneyuki Takeuchi  42 Neal J Thomas  43 Sze Man Tse  1 Stacey Valentine  44 Shan Ward  45 R Scott Watson  21   46 Nadir Yehya  30 Jerry J Zimmerman  40   47 Robinder G Khemani  8 Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) Group on behalf of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
Collaborators, Affiliations

Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2)

Guillaume Emeriaud et al. Pediatr Crit Care Med. .

Abstract

Objectives: We sought to update our 2015 work in the Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) guidelines for the diagnosis and management of pediatric acute respiratory distress syndrome (PARDS), considering new evidence and topic areas that were not previously addressed.

Design: International consensus conference series involving 52 multidisciplinary international content experts in PARDS and four methodology experts from 15 countries, using consensus conference methodology, and implementation science.

Setting: Not applicable.

Patients: Patients with or at risk for PARDS.

Interventions: None.

Measurements and main results: Eleven subgroups conducted systematic or scoping reviews addressing 11 topic areas: 1) definition, incidence, and epidemiology; 2) pathobiology, severity, and risk stratification; 3) ventilatory support; 4) pulmonary-specific ancillary treatment; 5) nonpulmonary treatment; 6) monitoring; 7) noninvasive respiratory support; 8) extracorporeal support; 9) morbidity and long-term outcomes; 10) clinical informatics and data science; and 11) resource-limited settings. The search included MEDLINE, EMBASE, and CINAHL Complete (EBSCOhost) and was updated in March 2022. Grading of Recommendations, Assessment, Development, and Evaluation methodology was used to summarize evidence and develop the recommendations, which were discussed and voted on by all PALICC-2 experts. There were 146 recommendations and statements, including: 34 recommendations for clinical practice; 112 consensus-based statements with 18 on PARDS definition, 55 on good practice, seven on policy, and 32 on research. All recommendations and statements had agreement greater than 80%.

Conclusions: PALICC-2 recommendations and consensus-based statements should facilitate the implementation and adherence to the best clinical practice in patients with PARDS. These results will also inform the development of future programs of research that are crucially needed to provide stronger evidence to guide the pediatric critical care teams managing these patients.

PubMed Disclaimer

Conflict of interest statement

Dr. Barbaro is currently receiving grant support (R01 HL153519; R01 HD015434) from the National Institutes of Health (NIH); he is currently Chair of the Extracorporeal Life Support Organization Registry. Dr. Bembea receives research funding to her institution from the NIH/National Institute of Neurological Disorders and Stroke (R01NS106292) and the Grifols Investigator Sponsored Research Grant. She serves as Chair of the Scientific Committee of the Pediatric Acute Lung Injury and Sepsis Investigators Research Network. Dr. Cheifetz is a medical consultant for Phillips and Medtronic. His institution receives research grant funding from the NIH. Dr. Cruces received funding from the Chilean Ministry of Sciences (Fondecyt 1220322). Dr. Curley received funding from the NIH (UH3HL141736, R01HD098269, R01HL149910, R01HL153519, R01HD104618). Dr. Dahmer received funding from the NIH (National Institute of Child Health and Human Development [NICHD], R21 HD097387; National Heart, Lung and Blood Institute [NHLBI] R01 HL149910). Dr. Dalton received funding from the Department of Defense (No. 13363072). She is a consultant for Innovative Extracorporeal Membrane Oxygenation Concepts, Hemocue, Entegrion, Medtronic, and advisory board member for Abiomed. Dr. Emeriaud’s research program is supported by the Fonds de Recherche du Québec-Santé and the Quebec Respiratory Health Network. Dr. Emeriaud is leading a study, which is financially supported by Maquet. Dr. Jouvet’s research program and salary is supported by the Fonds de Recherche du Québec-Santé and the Quebec Respiratory Health Network. Dr. Jouvet is leading studies, which is financially supported by VitalTracer, Dymedso and public financial agencies (Canadian Foundation for innovation, Institut TransMedTech, Quebec Ministry of Health, Sainte-Justine Hospital). Dr. Killien received funding from the NIH (NICHD K23HD100566). Dr. Kneyber received research funding from the NIH/NICHD (UG3 HL141736-01/U24 HL141723-01) and ZorgOnderzoek Nederland and the area Medical (848041002), Stichting Vrienden Beatrix Kinderziekenhuis, Fonds NutsOhra, University Medical Center Groningen, VU University Medical Center, and the Royal Academy of Dutch Sciences (TerMeulen stipend). Dr. Kneyber’s research program is technically supported by Vyaire, Applied Biosignals, and Timpl. Dr. Kneyber received honoraria from Vyaire. Dr. Kneyber serves as consultant for Metran and served as consultant for Vyaire. Dr. Kudchadkar received funding to her institution from the NIH/NICHD (R01HD103811 & R21HD093369) and the Donaghue Foundation. Dr. López-Fernández is funded by an academic grant from the Instituto de Salud Carlos III, Madrid, Spain (PI19/00141). Dr. Maddux received funding to her institution from the NIH/NICHD (K23HD096018). Dr. Morrow has received honoraria for Continuing Medical Education presentations from EduPro Health. Her research is part-funded by the National Research Foundation of South Africa, through the Incentive Funding for Rated Researchers program. Dr. Nadkarni receives unrestricted research grants to his institution from the NIH, U.S. Department of Defense, Agency for Healthcare Research and Quality, Laerdal Foundation, RQI Partners, Zoll Medical, Defibtech, HeartHero, and Nihon-Kohden. Dr. Nadkarni is an elected member of the Executive Committee (Council) of the Society of Critical Care Medicine. Dr. Napolitano research and consulting relationships with: Drager, Timpel, VERO-Biotech, Actuated Medical, and Philips/Respironics. Dr. Pons has been on the speaker’s bureau of Philips, ResMed and Fisher & Paykel; Hospital Sant Joan de Déu has received disposable material from these companies. Dr. Randolph receives funding from the Centers for Disease Control and Prevention, NIH (National Institute of Allergy and Infectious Diseases AI154470). Dr. Rowan receives funding from the NHLBI (NHLBI K23HL150244). Dr. Sanchez-Pinto received funding from the NIH (NICHD R01 HD105939). Dr. Sauthier research program and salary is supported by the Fonds de Recherche du Québec-Santé. Dr. Takeuchi receives funding from Japan Society for the Promotion of Science grant (KAKENHI 21K09063). Dr. Tse receives research funding to her institution from the Canadian Institute of Health Research and salary support from the Fonds de Recherche du Québec—Santé. Dr. Watson receives research funding to his institution from the NIH. Dr. Zimmerman received research funding from NIH and Biomedical Advanced Research and Development Authority; royalties from Elsevier Publishing. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Schematic summary of key therapies or management strategies in pediatric acute respiratory distress syndrome based on the Second Pediatric Acute Lung Injury Consensus Conference recommendations and statements. *Continuous positive airway pressure if unable to tolerate bilevel noninvasive ventilation (NIV). ECMO = extracorporeal membrane oxygenation, HFNC = high-flow nasal cannula, HFOV = high-frequency oscillatory ventilation, PEEP = positive end-expiratory pressure, SFo2 ratio = oxygen saturation/Fio2 ratio, Spo2 = pulse oximeter oxygen saturation, Vt = tidal volume.

References

    1. Force ADT, Ranieri VM, Rubenfeld GD, et al. : Acute respiratory distress syndrome: The Berlin definition. JAMA 2012; 307:2526–2533 - PubMed
    1. Pediatric Acute Lung Injury Consensus Conference Group: Pediatric acute respiratory distress syndrome. Pediatr Crit Care Med 2015; 16:428–439 - PMC - PubMed
    1. Quasney MW, Lopez-Fernandez YM, Santschi M, et al. : The outcomes of children with pediatric acute respiratory distress syndrome: Proceedings from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med 2015; 16:S118–S131 - PubMed
    1. Thomas NJ, Jouvet P, Willson D: Acute lung injury in children-kids really aren´t just little adults. Pediatr Crit Care Med 2013; 14:429–432 - PubMed
    1. Khemani RG, Smith LS, Zimmerman JJ, et al. : Pediatric acute respiratory distress syndrome: Definition, incidence, and epidemiology: Proceedings from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med 2015; 16:S23–S40 - PubMed

Publication types